Inman Jager Wealth Management’s AbbVie ABBV Stock Holding History

Inman Jager Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$337K	Hold	1,549	–	–	0.2%	70
2025 Q4	$354K	Hold	1,549	–	–	0.22%	70
2025 Q3	$359K	Buy	1,549 +225	+17%	+$45.8K	0.23%	67
2025 Q2	$246K	Sell	1,324 -1	-0.1%	-$186	0.17%	77
2025 Q1	$278K	Sell	1,325 -59	-4%	-$11.5K	0.21%	69
2024 Q4	$246K	Buy	+1,384	New	+$254K	0.19%	71

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Inman Jager Wealth Management's ABBV Position: Q1 2026 in Review

Inman Jager Wealth Management held its AbbVie (ABBV) position steady in Q1 2026 at 1,549 shares worth $337K. The position accounts for 0.2% of the portfolio, ranked #70.

Inman Jager Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $359K in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Inman Jager Wealth Management held 1,549 shares of AbbVie worth $337K as of Q1 2026.
Inman Jager Wealth Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.2% of Inman Jager Wealth Management's portfolio in Q1 2026, its #70 holding.
Inman Jager Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Inman Jager Wealth Management's AbbVie position peaked at $359K in Q3 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Inman Jager Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.